Literature DB >> 21292881

Characterization of Plasmodium vivax transmission-blocking activity in low to moderate malaria transmission settings of the Colombian Pacific coast.

Myriam Arévalo-Herrera1, Yezid Solarte, Leonardo Rocha, Diego Alvarez, John C Beier, Sócrates Herrera.   

Abstract

Malaria infection induces antibodies capable of suppressing the infectivity of gametocytes and gametes, however, little is known about the duration of the antibody response, the parasite specificity, and the role of complement. We report the analyses of the transmission-blocking (TB) activity of sera collected from 105 Plasmodium vivax-infected and 44 non-infected individuals from a malaria endemic region of Colombia, using a membrane feeding assay in Anopheles albimanus mosquitoes. In infected donors we found that TB activity was antibody dose dependent (35%), lasted for 2-4 months after infection, and in 70% of the cases different P. vivax wild isolates displayed differential susceptibility to blocking antibodies. Additionally, in a number of assays TB was complement-dependent. Twenty-seven percent of non-infected individuals presented TB activity that correlated with antibody titers. Studies here provide preliminary data on factors of great importance for further work on the development of TB vaccines.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21292881      PMCID: PMC3032493          DOI: 10.4269/ajtmh.2011.10-0085

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  30 in total

1.  Measurement by membrane feeding of reduction in Plasmodium falciparum transmission induced by endemic sera.

Authors:  A Lensen; J van Druten; M Bolmer; G van Gemert; W Eling; R Sauerwein
Journal:  Trans R Soc Trop Med Hyg       Date:  1996 Jan-Feb       Impact factor: 2.184

Review 2.  The paroxysm of Plasmodium vivax malaria.

Authors:  Nadira D Karunaweera; Subadra K Wijesekera; Deepani Wanasekera; Kamini N Mendis; Richard Carter
Journal:  Trends Parasitol       Date:  2003-04

3.  Molecular basis and PCR-DNA typing of the Fya/fyb blood group polymorphism.

Authors:  C Tournamille; C Le Van Kim; P Gane; J P Cartron; Y Colin
Journal:  Hum Genet       Date:  1995-04       Impact factor: 4.132

4.  Target antigens of transmission blocking immunity of Plasmodium vivax malaria. Characterization and polymorphism in natural parasite isolates.

Authors:  S Premawansa; J S Peiris; K L Perera; G Ariyaratne; R Carter; K N Mendis
Journal:  J Immunol       Date:  1990-06-01       Impact factor: 5.422

5.  Tumour necrosis factor-dependent parasite-killing effects during paroxysms in non-immune Plasmodium vivax malaria patients.

Authors:  N D Karunaweera; R Carter; G E Grau; D Kwiatkowski; G Del Giudice; K N Mendis
Journal:  Clin Exp Immunol       Date:  1992-06       Impact factor: 4.330

Review 6.  Vivax malaria: neglected and not benign.

Authors:  Ric N Price; Emiliana Tjitra; Carlos A Guerra; Shunmay Yeung; Nicholas J White; Nicholas M Anstey
Journal:  Am J Trop Med Hyg       Date:  2007-12       Impact factor: 2.345

7.  Transmission blocking immunity to human Plasmodium vivax malaria in an endemic population in Kataragama, Sri Lanka.

Authors:  A C Gamage-Mendis; J Rajakaruna; R Carter; K N Mendis
Journal:  Parasite Immunol       Date:  1992-07       Impact factor: 2.280

8.  Transmission blockade of Plasmodium falciparum malaria by anti-Pfs230-specific antibodies is isotype dependent.

Authors:  W Roeffen; F Geeraedts; W Eling; P Beckers; B Wizel; N Kumar; T Lensen; R Sauerwein
Journal:  Infect Immun       Date:  1995-02       Impact factor: 3.441

9.  Regular production of infective sporozoites of Plasmodium falciparum and P. vivax in laboratory-bred Anopheles albimanus.

Authors:  S Hurtado; M L Salas; J F Romero; J C Zapata; H Ortiz; M Arevalo-Herrera; S Herrera
Journal:  Ann Trop Med Parasitol       Date:  1997-01

10.  Cytokines kill malaria parasites during infection crisis: extracellular complementary factors are essential.

Authors:  T S Naotunne; N D Karunaweera; G Del Giudice; M U Kularatne; G E Grau; R Carter; K N Mendis
Journal:  J Exp Med       Date:  1991-03-01       Impact factor: 14.307

View more
  10 in total

Review 1.  Platform for Plasmodium vivax vaccine discovery and development.

Authors:  Sócrates Herrera Valencia; Diana Carolina Rodríguez; Diana Lucía Acero; Vanessa Ocampo; Myriam Arévalo-Herrera
Journal:  Mem Inst Oswaldo Cruz       Date:  2011-08       Impact factor: 2.743

Review 2.  Malaria vector species in Colombia: a review.

Authors:  James Montoya-Lerma; Yezid A Solarte; Gloria Isabel Giraldo-Calderón; Martha L Quiñones; Freddy Ruiz-López; Richard C Wilkerson; Ranulfo González
Journal:  Mem Inst Oswaldo Cruz       Date:  2011-08       Impact factor: 2.743

Review 3.  Malaria transmission blocking immunity and sexual stage vaccines for interrupting malaria transmission in Latin America.

Authors:  Myriam Arévalo-Herrera; Yezid Solarte; Catherin Marin; Mariana Santos; Jenniffer Castellanos; John C Beier; Sócrates Herrera Valencia
Journal:  Mem Inst Oswaldo Cruz       Date:  2011-08       Impact factor: 2.743

Review 4.  Evaluation of the Pfs25-IMX313/Matrix-M malaria transmission-blocking candidate vaccine in endemic settings.

Authors:  Charles Mulamba; Chris Williams; Katharina Kreppel; Jean Bosco Ouedraogo; Ally I Olotu
Journal:  Malar J       Date:  2022-06-02       Impact factor: 3.469

5.  Human host-derived cytokines associated with Plasmodium vivax transmission from acute malaria patients to Anopheles darlingi mosquitoes in the Peruvian Amazon.

Authors:  Shira R Abeles; Raul Chuquiyauri; Carlos Tong; Joseph M Vinetz
Journal:  Am J Trop Med Hyg       Date:  2013-03-11       Impact factor: 2.345

6.  Optimization of a Membrane Feeding Assay for Plasmodium vivax Infection in Anopheles albimanus.

Authors:  Andrés F Vallejo; Kelly Rubiano; Andres Amado; Amy R Krystosik; Sócrates Herrera; Myriam Arévalo-Herrera
Journal:  PLoS Negl Trop Dis       Date:  2016-06-29

7.  Malaria in pregnancy: a passive surveillance study of pregnant women in low transmission areas of Colombia, Latin America.

Authors:  Mary Lopez-Perez; M Andreína Pacheco; Lucía Buriticá; Ananias A Escalante; Sócrates Herrera; Myriam Arévalo-Herrera
Journal:  Malar J       Date:  2016-02-05       Impact factor: 2.979

Review 8.  Immunity against sexual stage Plasmodium falciparum and Plasmodium vivax parasites.

Authors:  Roos M de Jong; Surafel K Tebeje; Lisette Meerstein-Kessel; Fitsum G Tadesse; Matthijs M Jore; Will Stone; Teun Bousema
Journal:  Immunol Rev       Date:  2019-12-16       Impact factor: 12.988

9.  Immunoreactivity of Sera From Low to Moderate Malaria-Endemic Areas Against Plasmodium vivax rPvs48/45 Proteins Produced in Escherichia coli and Chinese Hamster Ovary Systems.

Authors:  Myriam Arévalo-Herrera; Kazutoyo Miura; Nora Cespedes; Carlos Echeverry; Eduardo Solano; Angélica Castellanos; Juan Sebastián Ramirez; Adolfo Miranda; Andrey V Kajava; Carole Long; Giampietro Corradin; Sócrates Herrera
Journal:  Front Immunol       Date:  2021-06-24       Impact factor: 7.561

10.  Plasmodium vivax sporozoite challenge in malaria-naïve and semi-immune Colombian volunteers.

Authors:  Myriam Arévalo-Herrera; David A Forero-Peña; Kelly Rubiano; José Gómez-Hincapie; Nora L Martínez; Mary Lopez-Perez; Angélica Castellanos; Nora Céspedes; Ricardo Palacios; José Millán Oñate; Sócrates Herrera
Journal:  PLoS One       Date:  2014-06-25       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.